OBJECTIVE: To evaluate the usefulness of early transcranial Doppler ultrasound (TCD) goal-directed therapy after severe traumatic brain injury initiated before invasive cerebral monitoring is available. DESIGN: Prospective, observational clinical study. SETTING: Surgical intensive care unit, university hospital. PATIENTS AND PARTICIPANTS: Twenty-four severely brain-injured patients. INTERVENTIONS: All patients had TCD measurements immediately on admission (T0) and when invasive cerebral monitoring was available (T1). TCD was considered abnormal when two out of three measured values were outside the following limits: Vm<30 cm/s, Vd<20 cm/s, PI > 1.4. When admission TCD was abnormal, attending physicians modified treatment to increase cerebral perfusion pressure. MEASUREMENTS AND RESULTS: Admission TCD was performed 18+/-11 min (T0) after admission, whereas cerebral invasive monitoring was available 242+/-116 min (T1) after admission. At T0, 11 (46%) patients had abnormal TCD values (group 1) and 13 had normal TCD values (group 2); mean arterial pressure was comparable between groups. All group 1 patients received mannitol and/or norepinephrine. At T1, mean arterial pressure was increased compared to admission in group 1 (105+/-17 mmHg vs. 89+/-15 mmHg, p<0.05) and only two patients had still an abnormal TCD. Although group 1 patients had higher intracranial pressure than those of group 2 (32+/-13 mmHg vs. 22+/-10 mmHg, p<0.01), both cerebral perfusion pressure and jugular venous oxygen saturation were comparable between the groups. CONCLUSIONS: The use of TCD at hospital admission allows identification of severely brain-injured patients with brain hypoperfusion. In such high-risk patients, early TCD goal-directed therapy can restore normal cerebral perfusion and might then potentially help in reducing the extent of secondary brain injury.
OBJECTIVE: To evaluate the usefulness of early transcranial Doppler ultrasound (TCD) goal-directed therapy after severe traumatic brain injury initiated before invasive cerebral monitoring is available. DESIGN: Prospective, observational clinical study. SETTING: Surgical intensive care unit, university hospital. PATIENTS AND PARTICIPANTS: Twenty-four severely brain-injured patients. INTERVENTIONS: All patients had TCD measurements immediately on admission (T0) and when invasive cerebral monitoring was available (T1). TCD was considered abnormal when two out of three measured values were outside the following limits: Vm<30 cm/s, Vd<20 cm/s, PI > 1.4. When admission TCD was abnormal, attending physicians modified treatment to increase cerebral perfusion pressure. MEASUREMENTS AND RESULTS: Admission TCD was performed 18+/-11 min (T0) after admission, whereas cerebral invasive monitoring was available 242+/-116 min (T1) after admission. At T0, 11 (46%) patients had abnormal TCD values (group 1) and 13 had normal TCD values (group 2); mean arterial pressure was comparable between groups. All group 1 patients received mannitol and/or norepinephrine. At T1, mean arterial pressure was increased compared to admission in group 1 (105+/-17 mmHg vs. 89+/-15 mmHg, p<0.05) and only two patients had still an abnormal TCD. Although group 1 patients had higher intracranial pressure than those of group 2 (32+/-13 mmHg vs. 22+/-10 mmHg, p<0.01), both cerebral perfusion pressure and jugular venous oxygen saturation were comparable between the groups. CONCLUSIONS: The use of TCD at hospital admission allows identification of severely brain-injured patients with brain hypoperfusion. In such high-risk patients, early TCD goal-directed therapy can restore normal cerebral perfusion and might then potentially help in reducing the extent of secondary brain injury.
Authors: Paul Jaffres; Julien Brun; Philippe Declety; Jean-Luc Bosson; Bertrand Fauvage; Almuth Schleiermacher; Affif Kaddour; Daniel Anglade; Claude Jacquot; Jean-Francois Payen Journal: Intensive Care Med Date: 2005-04-16 Impact factor: 17.440
Authors: S P Gopinath; C S Robertson; C F Contant; C Hayes; Z Feldman; R K Narayan; R G Grossman Journal: J Neurol Neurosurg Psychiatry Date: 1994-06 Impact factor: 10.154
Authors: Fabien Trabold; Philippe G Meyer; Stéphane Blanot; Pierre A Carli; Gilles A Orliaguet Journal: Intensive Care Med Date: 2003-11-05 Impact factor: 17.440
Authors: Jonathan P Coles; Tim D Fryer; Piotr Smielewski; Doris A Chatfield; Luzius A Steiner; Andrew J Johnston; Stephen P M J Downey; Guy B Williams; Franklin Aigbirhio; Peter J Hutchinson; Kenneth Rice; T Adrian Carpenter; John C Clark; John D Pickard; David K Menon Journal: J Cereb Blood Flow Metab Date: 2004-02 Impact factor: 6.200
Authors: Luzius A Steiner; Marek Czosnyka; Stefan K Piechnik; Piotr Smielewski; Doris Chatfield; David K Menon; John D Pickard Journal: Crit Care Med Date: 2002-04 Impact factor: 7.598
Authors: Pierre Bouzat; Gilles Francony; Julien Brun; Pierre Lavagne; Julien Picard; Christophe Broux; Philippe Declety; Claude Jacquot; Pierre Albaladejo; Jean-Francois Payen Journal: Intensive Care Med Date: 2010-05-20 Impact factor: 17.440
Authors: Karol P Budohoski; Matthias Reinhard; Marcel J H Aries; Zofia Czosnyka; Peter Smielewski; John D Pickard; Peter J Kirkpatrick; Marek Czosnyka Journal: Neurocrit Care Date: 2012-10 Impact factor: 3.210
Authors: Shaji Philip; Onuma Chaiwat; Yuthana Udomphorn; Anne Moore; Jerry J Zimmerman; William Armstead; Monica S Vavilala Journal: Crit Care Med Date: 2009-11 Impact factor: 7.598
Authors: Thomas Geeraerts; Yoann Launey; Laurent Martin; Julien Pottecher; Bernard Vigué; Jacques Duranteau; Dan Benhamou Journal: Intensive Care Med Date: 2007-08-01 Impact factor: 17.440